Sagimet Biosciences Inc. (SGMT) Corporate Subsidiaries
Sagimet Biosciences Inc. (SGMT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SGMT
CIK: 1400118
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerRyan Breen
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-07 | — | SCHEDULE 13G Filing | 0001831942-26-000045 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-09-30 | 8-K | 0001193125-26-409335 | View SEC Doc Filr Page |
| 424B5 | 2026-10-01 | — | 424B5 | 0001193125-26-409325 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-30 | 8-K | 0001193125-26-408224 | View SEC Doc Filr Page |
| 424B3 | 2026-09-30 | — | 424B3 | 0001193125-26-408210 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | 4 | 0001193125-26-354018 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001950047-26-008152 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001172661-26-003438 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-347854 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-11 | 4 | 0001193125-26-347407 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001950047-26-007964 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-343446 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-343441 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-30 | — | SCHEDULE 13G Filing | 0002012383-26-003143 | View SEC Doc Filr Page |
| 4 | 2026-07-22 | 2026-07-20 | 4 | 0001193125-26-312397 | View SEC Doc Filr Page |
| 4 | 2026-07-22 | 2026-07-20 | 4 | 0001193125-26-312394 | View SEC Doc Filr Page |
| 4 | 2026-07-22 | 2026-07-20 | 4 | 0001193125-26-312386 | View SEC Doc Filr Page |
| 8-K | 2026-07-21 | 2026-07-20 | 8-K | 0001193125-26-309334 | View SEC Doc Filr Page |
| 144 | 2026-07-20 | — | 144 Filing | 0001950047-26-007226 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | OWNERSHIP DOCUMENT | 0001104659-26-074055 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | OWNERSHIP DOCUMENT | 0001104659-26-074052 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | OWNERSHIP DOCUMENT | 0001104659-26-074050 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | OWNERSHIP DOCUMENT | 0001104659-26-074047 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | OWNERSHIP DOCUMENT | 0001104659-26-074045 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | OWNERSHIP DOCUMENT | 0001104659-26-074044 | View SEC Doc Filr Page |